Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jan 10, 2025
8-K Jan 6, 2025 8-K
4 Dec 26, 2024 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Dec 26, 2024
144 Dec 20, 2024
4 Dec 16, 2024 OWNERSHIP DOCUMENT
8-K Nov 29, 2024 8-K
SC 13G/A Nov 14, 2024 FATE THERAPEUTICS, INC.
10-Q Nov 12, 2024 10-Q
8-K Nov 12, 2024 8-K
SC 13G/A Nov 8, 2024
SC 13G/A Oct 25, 2024
SC 13G/A Oct 21, 2024
8-K Aug 30, 2024 8-K
3 Aug 21, 2024 3
10-Q Aug 13, 2024 10-Q
8-K Aug 13, 2024 8-K
4 Aug 7, 2024 4
144 Aug 6, 2024
4 Jul 31, 2024 4
4 Jul 31, 2024 4
4 Jul 31, 2024 4
3 Jul 31, 2024 3
8-K Jul 31, 2024 8-K
4 Jun 11, 2024 OWNERSHIP DOCUMENT
← Newer Page 5 of 34 · 849 filings Older →